Poland – Pharmaceutical products – 244/PN/2026 - Dostawa produktów leczniczych w ramach importu docelowego dla UCK
Uniwersyteckie Centrum Kliniczne
Buyer country
Poland
Publication date
Not specified
Biderra sector
Pharma and laboratory
Data source
TED open data
Decision signals
First-pass opportunity review
These signals are calculated from the indexed fields. They help prioritize a review but do not replace eligibility checks in the official procurement documents.
- Timing signal
- Deadline not indexed
- Indexed data completeness
- 86%
- Official title coverage
- 7 languages
- Classification signal
- 33600000
Check the official notice
Based on seven decision fields
Preserved from source-supplied versions
Medical equipment, pharmaceuticals and personal care products
Official title versions
TED may publish the same notice title in several official languages. Biderra preserves the versions supplied in the source feed.
Polonia – Productos farmacéuticos – 244/PN/2026 - Dostawa produktów leczniczych w ramach importu docelowego dla UCK
Polen – Farmaceutische producten – 244/PN/2026 - Dostawa produktów leczniczych w ramach importu docelowego dla UCK
Polska – Produkty farmaceutyczne – 244/PN/2026 - Dostawa produktów leczniczych w ramach importu docelowego dla UCK
Pologne – Produits pharmaceutiques – 244/PN/2026 - Dostawa produktów leczniczych w ramach importu docelowego dla UCK
Polen – Arzneimittel – 244/PN/2026 - Dostawa produktów leczniczych w ramach importu docelowego dla UCK
Polonia – Prodotti farmaceutici – 244/PN/2026 - Dostawa produktów leczniczych w ramach importu docelowego dla UCK
Poland – Pharmaceutical products – 244/PN/2026 - Dostawa produktów leczniczych w ramach importu docelowego dla UCK
What Biderra adds
For notice 594634-2026, Biderra has normalized the contracting authority country as Poland, grouped CPV 33600000 under pharma and laboratory, compared the available deadline fields with today, measured field completeness, and preserved 7 source-supplied title versions. The official record remains decisive.